Abstract | CONTEXT AND OBJECTIVE: Human hepatocellular carcinoma (HCC) is a severe malignant disease, and accurate and reliable diagnostic markers are still needed. This study was aimed for the discovery of novel marker candidates by quantitative proteomics. METHODS AND RESULTS: Proteomic differences between HCC and nontumorous liver tissue were studied by mass spectrometry. Among several significantly upregulated proteins, translocator protein 18 (TSPO) and Ras-related protein Rab-1A (RAB1A) were selected for verification by immunohistochemistry in an independent cohort. For RAB1A, a high accuracy for the discrimination of HCC and nontumorous liver tissue was observed. CONCLUSION: RAB1A was verified to be a potent biomarker candidate for HCC.
|
Authors | Dominik Andre Megger, Kristin Rosowski, Maike Ahrens, Thilo Bracht, Martin Eisenacher, Jörg F Schlaak, Frank Weber, Andreas-Claudius Hoffmann, Helmut E Meyer, Hideo A Baba, Barbara Sitek |
Journal | Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals
(Biomarkers)
Vol. 22
Issue 2
Pg. 113-122
(Mar 2017)
ISSN: 1366-5804 [Electronic] England |
PMID | 27467182
(Publication Type: Journal Article)
|
Chemical References |
- Biomarkers, Tumor
- Proteome
- rab1 GTP-Binding Proteins
|
Topics |
- Biomarkers, Tumor
(analysis)
- Carcinoma, Hepatocellular
(diagnosis)
- Humans
- Liver Neoplasms
(diagnosis)
- Proteome
(analysis)
- Proteomics
(methods)
- Tandem Mass Spectrometry
- Up-Regulation
- rab1 GTP-Binding Proteins
(analysis)
|